1792
S. Takizawa et al. / Tetrahedron 70 (2014) 1786e1793
127.9, 127.0, 126.5, 125.7, 124.9, 124.7, 123.8, 121.1, 120.3, 109.8;
6.6. Transformation of (S)-1b
HRMS (ESI-TOF): calcd for C36H22O2Na [MþNa]þ 509.1517, found:
m/z 509.1511; IR (KBr): 3457, 2989, 1763, 1376, 1242, 1056 cmꢀ1
;
6.6.1. Preparation of (S)-10. To a 5 mL round-bottomed flask at rt
was added (S)-1b (50 mg, 0.13 mmol), and PtO2 (31.7 mg,
0.12 mmol) in glacial acetic acid (1.5 mL). The flask was furnished
with a stream of hydrogen (1 atm) at rt. After stirring for 5 days, the
reaction mixture was filtered by Celite to remove PtO2. The mother
liquid was washed with H2O, and then evaporated. The crude was
purified by column chromatography to give (S)-10 in 80% yield
Daicel Chiralpak AD-H column, 2-propanol/n-hexane¼3/17, flow
rate 1.0 mL/min, 11.9 min (S-isomer) and 23.2 min (R-isomer).
6.3. Preparation of mononuclear vanadium complex (S)-5b
A
round bottomed flask was charged with 2-hydroxy-1-
(42 mg, 0.10 mmol) as a pale brown solid.
21
naphthaldehyde (1.46 mmol), which were prepared according to
the known method, (S)-tert-leucine (1.60 mmol), MS 3A (0.73 g)
and EtOH (25 mL). The reaction mixture was refluxed at 80 ꢁC and
consumption of the aldehyde substrate was monitored by TLC. After
evaporation of EtOH, the residue was suspended in CH2Cl2 (15 mL)
and then VOCl3 (3.21 mmol) was added. The reaction mixture was
stirred for 12 h, and filtered by Celite to remove MS 3A. The filtrate
was evaporated and the resulting black solid was dissolved in
MeOH and the solvent was evaporated again. The residue was
collected by filtration and washed sequentially with water and
ether, and then dried in a vacuum to give (S)-5b in 58% yield as
a black powder.
(S)-10: Mp 177e179 ꢁC; >99% ee, [
a
]
ꢀ32.9 (c 0.5, CHCl3, for
D
>99% ee); 1H NMR (CDCl3):
d
4.60 (br, s, 2H), 2.78e2.43 (m, 12H),
149.1,
2.35e2.08 (m, 4H), 1.94e1.54 (m, 16H); 13C NMR (CDCl3):
d
137.3, 132.6, 127.7, 121.7, 115.6, 27.7, 26.7, 26.2, 23.7, 23.3, 23.1, 22.9,
22.2; HRMS (ESI-TOF): calcd for C28H34O2Na [MþNa]þ 425.2451,
found: m/z 425.2452; IR (KBr): 3517, 2928, 2860, 1438, 1301,
1212 cmꢀ1
.
6.6.2. Preparation of (S)-11. To
a
solution of (S)-1b (1.0 g,
2.58 mmol) in anhydrous acetone (20 mL) was added to anhydrous
K2CO3 (1.43 g, 10.4 mmol) and methyl iodide (1.83 g, 12.9 mmol).
The reaction mixture was heated at 50 ꢁC under Ar atmosphere for
4 h. After cooling to rt, the volatiles were removed in vacuum and
the residues were washed with CH2Cl2. The organic layers were
dried over anhydrous Na2SO4 and then evaporated. The crude was
purified by column chromatography to give (S)-11 in 80% yield
(0.85 g, 2.06 mmol) as a white solid.
(S)-5b: 1H NMR (CD3OD):
d
9.48 (s, 1H), 8.29 (d, J¼8.6 Hz, 1H),
8.09 (d, J¼9.1 Hz, 1H), 7.87 (d, J¼8.6 Hz, 1H), 7.63 (t, J¼7.2 Hz, 1H),
7.43 (t, J¼7.2 Hz, 1H), 7.14 (d, J¼9.1 Hz, 1H), 4.37 (s, 1H), 1.28 (s, 9H);
13C NMR (CD3OD);
d 180.3, 165.8, 163.3, 138.7, 134.9, 130.5, 130.04,
130.00, 125.4,121.4, 120.9, 112.6, 85.4, 38.3, 28.2; 51V NMR (CD3OD):
d
ꢀ558.3; HRMS (ESI-TOF): calcd for C18H20NO5VNa
(S)-115a: Mp 255e257 ꢁC; >99% ee, [
a]
D
25 þ35.8 (c 1.0, CHCl3, for
[MeOHþOMeþNa]þ 404.0678, found: m/z 404.0674; IR (KBr):
>99% ee); 1H NMR (CDCl3)
d
8.84 (d, J¼8.1 Hz, 2H), 8.77 (d, J¼8.3 Hz,
3233, 2961, 1672, 1612, 1335, 971 cmꢀ1
.
2H), 8.34 (d, J¼9.5 Hz, 2H), 7.80e7.70 (m, 4H), 7.58e7.55 (m, 2H),
7.34e7.33 (m, 4H), 3.57 (s, 6H); 13C NMR (CDCl3)
152.7, 132.9, 132.0,
128.2,128.1,127.2,126.9ꢂ2,126.8,125.5,123.6,122.9,122.7,122.3, 61.2.
d
6.4. Preparation of organocatalyst (S)-6d
6.6.3. Preparation of (S)-12. To solution of (S)-11 (50 mg,
a
The organocatalyst (S)-6d was prepared according to the liter-
0.12 mmol) in MeCN (2 mL) was gradually added to NBS (107 mg,
0.6 mmol). The reaction mixture was stirred for 2 h under reflux
conditions. The volatiles were removed in vacuum and the residues
were washed with water, brine, and CH2Cl2. The organic layers
were dried over anhydrous Na2SO4 and then evaporated. The crude
was purified by column chromatography to give (S)-12 in quanti-
ature method.8a
22
(S)-6d: [
a
]
þ822.0 (c 0.2, CHCl3, for 96% ee); 1H NMR (CDCl3)
D
d
9.71 (d, J¼7.6 Hz, 2H), 8.75e8.63 (m, 4H), 7.90e7.19 (m, 14H); 13
C
NMR (CDCl3)
d 146.68, 146.62, 143.2, 140.7, 133.0, 131.61, 131.25,
129.8, 129.2, 128.5, 128.2, 127.6, 127.3, 126.7, 126.4, 125.9, 125.0,
123.5, 123.0, 122.6, 120.7; 31P NMR (CDCl3)
d
1.62; HRMS (ESI-TOF):
tative yield (68 mg, 0.12 mmol).
23
calcd for C36H21O4PNa [MþNa]þ 571.1070, found: m/z 571.1072; IR
(S)-12: Mp 282e284 ꢁC; >99% ee, [
a
]
ꢀ17.4 (c 1.0, CHCl3, for
D
(KBr): 3438, 2938, 1744, 1365, 1211, 1090 cmꢀ1
.
>99% ee); 1H NMR (CDCl3)
2H), 8.33e8.32 (m, 2H), 7.79e7.74 (m, 4H), 7.43e7.39 (m, 2H),
7.17e7.13 (m, 2H), 3.55 (s, 6H); 13C NMR (CDCl3)
153.2, 131.4, 131.0,
d
8.89 (d, J¼2.0 Hz, 2H), 8.74e8.72 (m,
d
6.5. General procedure for direct organocatalytic enantiose-
lective DielseAlder reaction of 2-cyclohexenone (7) and aldi-
mines 8
130.2, 129.8, 128.3, 128.2, 127.7, 127.6, 125.6, 123.7, 123.0, 121.3,
120.1, 61.3; HRMS (ESI-TOF): calcd for C30H20Br2O2Na [MþNa]þ
594.9702, found: m/z 594.9702; IR (KBr): 3071, 2947, 1588, 1428,
1118, 1086 cmꢀ1
.
2-Cyclohexenone (7) (0.07 mL, 0.73 mmol) was added to a vial
containing aldimines 8 (0.073 mmol) and a catalytic amount of
phosphoric acid 6 (5 mol %) in toluene (0.27 mL) at rt. After vig-
orously stirring the mixture for 72 h, the reaction mixture was di-
rectly purified by column chromatography on silica gel to afford 9.
6.6.4. Preparation of (S)-13. To a solution of (S)-12 (200 mg,
0.36 mmol) in CH2Cl2 (4 mL) was slowly added to BBr3 (1 M solution
in CH2Cl2) (0.76 mL, 0.76 mmol) at 0 ꢁC under Ar atmosphere. The
reaction mixture was stirred for overnight. After addition of water
(1 mL), the mixture was extracted with CH2Cl2. The organic layers
were washed with water, brine, and dried over anhydrous Na2SO4.
After the evaporation, (S)-13 was obtained in 70% yield (130 mg,
endo-9c: 34% ee, [
(CDCl3)
a
]
20 þ32.7 (c 0.6, CHCl3, for 34% ee); 1H NMR
D
d
7.83e7.74 (m, 4H), 7.45e7.39 (m, 3H), 6.75 (dd, J¼6.6,
2.2 Hz, 2H), 6.66 (dd, J¼6.6, 3.2 Hz, 2H), 4.72 (s, 1H), 4.50 (s, 1H),
3.70 (s, 3H), 2.88e2.83 (m, 2H), 2.49 (dd, J¼18.8, 2.7 Hz, 1H),
2.37e2.29 (m, 1H), 2.25e2.15 (m, 1H), 2.11e2.03 (m, 1H), 1.81e1.74
0.25 mmol) as a white solid.
25
(S)-13: Mp 303e305 ꢁC; >99% ee, [
a
]
ꢀ49.6 (c 0.5, CHCl3, for
D
(m, 1H); 13C NMR (CDCl3)
d
211.8, 152.1, 142.5, 139.6, 133.6, 133.0,
>99% ee); 1H NMR (CDCl3)
d
8.85 (d, J¼2.0 Hz, 2H), 8.70 (d, J¼8.3 Hz,
128.9, 128.1, 127.7, 126.1, 125.8, 124.6, 123.8, 114.8, 114.6, 66.5, 55.6,
52.0, 49.3, 46.2, 22.8, 22.3; HRMS (ESI-TOF): calcd for C24H23NO2Na
[MþNa]þ 380.1621, found: m/z 380.1621; IR (KBr): 3422, 2948,
2372, 1721, 1510, 1248 cmꢀ1; Daicel Chiralpak AD-H column, 2-
propanol/n-hexane¼1/20, flow rate 1.0 mL/min, 28.8 min (minor
isomer) and 39.8 min (major isomer).
2H), 8.44 (d, J¼8.3 Hz, 2H), 7.85e7.81 (m, 2H), 7.76e7.72 (m, 2H),
7.41 (dd, J¼8.8, 2.0 Hz, 2H), 7.06 (d, J¼8.8 Hz, 2H), 5.58 (s, 2H); 13
C
NMR (CDCl3)
d 149.9, 131.0, 130.8, 130.2, 128.8, 128.7, 127.7, 126.7,
125.9, 125.1, 123.7, 122.8, 119.2, 106.3; HRMS (ESI-TOF): calcd for
C
28H14Br2O2Na [MeH2þNa]þ 564.9233, found: m/z 564.9231; IR
(KBr): 3488, 1591, 1491, 1423, 1207, 1002, 672 cmꢀ1
.